Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virios Therapeutics Inc
(NQ:
VIRI
)
0.1800
-0.0050 (-2.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virios Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
September 19, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.
Via
Benzinga
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
US Markets Turn Higher As Dow Jumps Over 100 Points
September 19, 2022
U.S. stocks traded higher in volatile trading toward the end of trading, with the Dow Jones gaining more than 100 points on Monday.
Via
Benzinga
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision
September 19, 2022
U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday.
Via
Benzinga
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
September 19, 2022
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Virios Therapeutics: Q1 Earnings Insights
May 12, 2022
Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
On Monday, 429 stocks made new 52-week lows.
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
Analyzing Virios Therapeutics's Short Interest
September 19, 2022
Virios Therapeutics's (NASDAQ:VIRI) short percent of float has risen 6.58% since its last report. The company recently reported that it has 53 thousand shares sold short, which is...
Via
Benzinga
Why Is Virios Therapeutics (VIRI) Stock Down 71% Today?
September 19, 2022
Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b Study of IMC-1 in Fibromyalgia.
Via
InvestorPlace
US Stocks Open Lower; Housing Market Index Drops In September
September 19, 2022
U.S. stocks traded lower this morning, after recording losses in the previous week.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 19, 2022
Via
Benzinga
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
September 19, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
Virios Therapeutics Commences Mid-Stage Long-COVID Study
August 15, 2022
Virios Therapeutics (Nasdaq: VIRI) has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib).
Via
Benzinga
Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
August 15, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics, Inc. to Present at Investor Summit Group’s Q3 Virtual Conference
August 10, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
August 09, 2022
Via
ACN Newswire
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
August 08, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Virios Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Thursday, August 11, 2022
August 04, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics (Nasdaq: VIRI) Advancing Potential Paradigm Shift in Fibromyalgia Treatment
July 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results
July 19, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 15, 2022
Via
Benzinga
Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia
June 01, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
May 12, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.